Binimetinib and encorafenib for the treatment of advanced solid tumors with non-V600E BRAF mutations: results from the Phase II BEAVER trial

Journal:

Nature Communications

Published:

2026-01-03

DOI:

10.1038/s41467-025-68076-7

Affiliations:

12

Authors:

29

Go to article

Institutions	Authors	Share
Princess Margaret Cancer Centre, U of T, Canada	11.366667 11.366667	0.39
University of Toronto (U of T), Canada	6.333333	0.22
McGill University, Canada	3.733333	0.13
Sir Mortimer B. Davis Jewish General Hospital (SMBD JGH), Canada	3.233333	0.11
McGill University Health Centre (MUHC), Canada	1.500000	0.05
University Health Network (UHN), U of T, Canada	1.500000	0.05
Montreal Neurological Institute and Hospital (MNI), McGill University, Canada	1.000000	0.03
Ontario Institute for Cancer Research (OICR), Canada	0.333333	0.01

Interested in Oncology and Carcinogenesis?